The smoking prevalence in the United States was forecast to continuously decrease between 2024 and 2029 by in total *** percentage points. After the ****** consecutive decreasing year, the smoking prevalence is estimated to reach ***** percent and therefore a new minimum in 2029. Shown is the estimated share of the adult population (15 years or older) in a given region or country, that smoke on a daily basis. According to the WHO and World bank, smoking refers to the use of cigarettes, pipes or other types of tobacco.The shown data are an excerpt of Statista's Key Market Indicators (KMI). The KMI are a collection of primary and secondary indicators on the macro-economic, demographic and technological environment in up to *** countries and regions worldwide. All indicators are sourced from international and national statistical offices, trade associations and the trade press and they are processed to generate comparable data sets (see supplementary notes under details for more information).Find more key insights for the smoking prevalence in countries like Canada and Mexico.

As of 2023, the U.S. states with the highest smoking rates included West Virginia, Tennessee, and Louisiana. In West Virginia, around 20 percent of all adults smoked as of this time. The number of smokers in the United States has decreased over the past decades. Who smokes? The smoking rates for both men and women have decreased for many years, but men continue to smoke at higher rates than women. As of 2021, around 13 percent of men were smokers compared to 10 percent of women. Concerning race and ethnicity, smoking is least prevalent among Asians with just five percent of this population smoking compared to 13 percent of non-Hispanic whites. Health impacts of smoking The negative health impacts of smoking are vast. Smoking increases the risk of heart disease, stroke, and many different types of cancers. For example, smoking is estimated to be attributable to 81 percent of all deaths from lung cancer among adults 30 years and older in the United States. Smoking is currently the leading cause of preventable death in the United States.

In 2022, the prevalence of smoking among white U.S. adults was 12.7 percent. This statistic represents the prevalence of smoking in the United States as of 2022, by race and ethnicity.

United States US: Smoking Prevalence: Total: % of Adults: Aged 15+ data was reported at 21.800 % in 2016. This records a decrease from the previous number of 22.300 % for 2015. United States US: Smoking Prevalence: Total: % of Adults: Aged 15+ data is updated yearly, averaging 23.900 % from Dec 2000 (Median) to 2016, with 9 observations. The data reached an all-time high of 31.400 % in 2000 and a record low of 21.800 % in 2016. United States US: Smoking Prevalence: Total: % of Adults: Aged 15+ data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of smoking is the percentage of men and women ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis. It excludes smokeless tobacco use. The rates are age-standardized.; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

From 1965 to 2022, the prevalence of cigarette smoking in the U.S. has decreased from about ** percent to ** percent. Cigarette smoking is a known risk factor for many types of cancers, including lung cancer, bladder cancer and pancreatic cancer. Globally, tobacco use is one of the greatest risk factors for preventable diseases. There are several resources in the United States to help individuals quit smoking, including websites, hotlines, medications and text message programs. Smoking prevalence globally Globally, smoking prevalence has also decreased, and is projected to continue to decline through 2025. North America comprises a small percentage of the world’s cigarette smokers. The highest prevalence of tobacco smoking can be found in Europe, followed by the Western Pacific. In the past few decades, there have been stronger efforts made to reduce cigarette consumption in many parts of the world. Cigarettes are taxed separately in many countries and are often required to add health warnings to cigarette packaging for consumers. Smoking cessation measures Smoking prevention measures cover a broad range of targeted cigarette reduction. Common tobacco control policies include warning labels, advertising bans, and smoke-free environments. As of 2022, around ** percent of the world population lived in a place where there were warning labels on tobacco products.

United States US: Smoking Prevalence: Males: % of Adults data was reported at 24.600 % in 2016. This records a decrease from the previous number of 25.100 % for 2015. United States US: Smoking Prevalence: Males: % of Adults data is updated yearly, averaging 26.800 % from Dec 2000 (Median) to 2016, with 9 observations. The data reached an all-time high of 34.500 % in 2000 and a record low of 24.600 % in 2016. United States US: Smoking Prevalence: Males: % of Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of smoking, male is the percentage of men ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis. It excludes smokeless tobacco use. The rates are age-standardized.; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

Graph and download economic data for Tobacco Consumption, Small Cigarettes for United States (M0187AUSM241NNBR) from Jan 1915 to Dec 1944 about tobacco, consumption, and USA.

Per capita cigarette consumption in the United States has decreased in recent years, with smokers in 2015 consuming an average of 1,078 cigarettes per capita. In total, there were around 267 billion cigarettes consumed in the U.S. that year. Cigarette consumption in the U.S. has decreased due to public policies limiting where people can smoke, higher taxes on cigarettes, and increased awareness by the general public of the health risks associated with smoking.

Smokers in the U.S.

Even though cigarette consumption has decreased, there are still around 38 million people in the U.S. who regularly smoke cigarettes. This is around 15.5 percent of the entire population. However, in the year 2000, 23 percent of the population smoked, a significant difference from present day figures. Smoking remains more common among males than females and rates of smoking among adolescents have decreased.

Health risks

Smoking has been proven to increase the risk of a variety of diseases and is the leading cause of preventable death in the U.S. Smoking harms almost every organ in the body and increases a person’s chance of developing lung cancer, heart disease, and stroke. For example, men who smoke are 25 times more likely to develop lung cancer than men who don’t smoke. Furthermore, around 81 percent of all deaths from lung, bronchus and trachea cancer can be attributed to cigarette smoking.

This report uses 2012 to 2014 National Survey on Drug Use and Health (NSDUH) data to percentages of past month cigarette use, average number of cigarettes smoked in the past month, prevalence of smoking cessation among adults with past year mental illness in comparison to adults with no past year mental illness.

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of people who do and do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete the Youth Interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled Primary Sampling Units (PSUs) and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This second replenishment sample was combined for estimation and analysis purposes with Wave 7 adult and youth respondents from the Wave 4 Cohort who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7. This combined set of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts. Dataset 0001 (DS0001) contains the data from the Public-Use File Master Linkage File (PUF-MLF). This file contains 93 variables and 82,139 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Public-Use Files and Special Collection Public-Use Files. Dataset 0002 (DS0002) contains the data from the Restricted-Use File Master Linkage File (RUF-MLF). This file contains 198 variables and 82,139 cases. The file provides a master list of every person's unique identification number and what type of respondent they were in each wave for data that are available in the Restricted-Use Files, Special Collection Restricted-Use Files, and Biomarker Restricted-Use Files.

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of people who use or do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled primary sampling units (PSU)s and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This "second replenishment sample" was combined for estimation and analysis purposes with the Wave 7 adult and youth respondents from the Wave 4 Cohorts who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts. Wave 4.5 was a special data collection for youth only who were aged 12 to 17 at the time of the Wave 4.5 interview. Wave 4.5 was the fourth annual follow-up wave for those who were members of the Wave 1 Cohort. For those who were sampled at Wave 4, Wave 4.5 was the first annual follow-up wave. Wave 5.5, conducted in 2020, was a special data collection for Wave 4 Cohort youth and young adults ages 13 to 19 at the time of the Wave 5.5 interview. Also in 2020, a subsample of Wave 4 Cohort adults ages 20 and older were interviewed via the PATH Study Adult Telephone Survey (PATH-ATS). Wave 7.5 was a special collection for Wave 4 and Wave 7 Cohort youth and young adults ages 12 to 22 at the time of the Wave 7.5 interview. For those who were sampled at Wave 7, Wave 7.5 was the first annual follow-up wave. Dataset 1002 (DS1002) contains the data from the Wave 4.5 Youth and Parent Questionnaire. This file contains 1,617 variables and 13,131 cases. Of these cases, 11,378 are continuing youth having completed a prior Youth Interview. The other 1,753 cases are "aged-up youth" having previously been sampled as "shadow youth" Datasets 1112, 1212, and 1222, (DS1112, DS1212, and DS1222) are data files comprising the weight variables for Wave 4.5. The "all-waves" weight file contains weights for participants in the Wave 1 Cohort who completed a Wave 4.5 Youth Interview and completed interviews (if old enough to do so) or verified their information with the study (if not old enough to be interviewed) in Waves 1, 2, 3, and 4. There are two separate files with "single wave" weights: one for the Wave 1 Cohort and one for the Wave 4 Cohort. The "single-wave" weight file for the Wave 1 Cohort contains weights for youth who c

United States US: Prevalence of Current Tobacco Use: % of Adults data was reported at 24.300 % in 2022. This records a decrease from the previous number of 24.700 % for 2021. United States US: Prevalence of Current Tobacco Use: % of Adults data is updated yearly, averaging 27.100 % from Dec 2000 (Median) to 2022, with 8 observations. The data reached an all-time high of 31.500 % in 2000 and a record low of 24.300 % in 2022. United States US: Prevalence of Current Tobacco Use: % of Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.a.1 [https://unstats.un.org/sdgs/metadata/]. Previous indicator name: Smoking prevalence, total (ages 15+) The previous indicator excluded smokeless tobacco use, while the current indicator includes. The indicator name and definition were updated in December, 2020.

Graph and download economic data for Expenditures: Tobacco Products and Smoking Supplies: All Consumer Units (CXUTOBACCOLB0101M) from 1984 to 2023 about tobacco, consumer unit, supplies, expenditures, and USA.

As of 2022, around **** million adults in the United States were current cigarette smokers. Although this figure is still high, it is significantly lower compared to previous years. For example, in 2011, there were almost ** million smokers in the United States. Smoking demographics in the U.S. Although smoking in the U.S. has decreased greatly over the past few decades, it is still more common among certain demographics than others. For example, men are more likely to be current cigarette smokers than women, with ** percent of men smoking in 2021, compared to ** percent of women. Furthermore, non-Hispanic whites and non-Hispanic Blacks smoke at higher rates than Hispanics and non-Hispanic Asians, with almost ** percent of non-Hispanic whites smoking in 2022, compared to just under **** percent of non-Hispanic Asians. Certain regions and states also have a higher prevalence of smoking than others, with around ** percent of adults in West Virginia considered current smokers, compared to just *** percent in Utah. The health impacts of smoking The decrease in smoking rates in the United States over the past decades is due to many factors, including policies and regulations limiting cigarette advertising, promotion, and sales, price increases for cigarettes, and widespread awareness among the public of the dangers of smoking. According to the CDC, those who smoke are *** to **** times more likely to develop coronary heart disease and stroke and around ** times more likely to develop lung cancer than nonsmokers. In fact, it is estimated that around ** percent of lung cancer deaths in the United States can be attributed to cigarette smoking, as well as ** percent of larynx cancer deaths. Cigarette smokers are also much more likely to develop chronic obstructive pulmonary disease (COPD), with around ** percent of current smokers in the U.S. living with COPD in 2021, compared to just ***** percent of those who had never smoked.

United States US: Prevalence of Current Tobacco Use: Males: % of Male Adults data was reported at 29.900 % in 2022. This records a decrease from the previous number of 30.400 % for 2021. United States US: Prevalence of Current Tobacco Use: Males: % of Male Adults data is updated yearly, averaging 33.000 % from Dec 2000 (Median) to 2022, with 8 observations. The data reached an all-time high of 37.800 % in 2000 and a record low of 29.900 % in 2022. United States US: Prevalence of Current Tobacco Use: Males: % of Male Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. The percentage of the male population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.a.1 [https://unstats.un.org/sdgs/metadata/]. Previous indicator name: Smoking prevalence, males (% of adults) The previous indicator excluded smokeless tobacco use, while the current indicator includes it. The indicator name and definition were updated in December, 2020.

Graph and download economic data for Consumer Price Index for All Urban Consumers: Tobacco and Smoking Products in U.S. City Average (CUSR0000SEGA) from Jan 1986 to Jul 2025 about tobacco, urban, production, consumer, CPI, inflation, price index, indexes, price, and USA.

When using any of this project's data, please reference the correct peer-reviewed publication listed below. Please see the publication for additional details on how the measures are constructed. Where multiple versions of the data exist, we recommend using the most recent version for new projects.E-cigarette Taxes: E-cigarette tax scheme vary across states and localities, making comparisons across states difficult. This project provides standardized e-cigarette tax rates at the state and local levels in the United States. 2nd Edition:Publication: Cotti, Chad, Erik Nesson, Michael F. Pesko, and Serena Phillips. "Standardising the measurement of e-cigarette taxes in the USA (2nd edition), 2010–2023 ." Tobacco control (2024). Accepted, in press.PubMed LInk: TBDDownload: E-cig Tax Version 2, 2010-2023.xlsxDescription: The downloadable data file includes 2 tabs:Closed System E-cigarette Taxes by State/County from 2010 to 2023, 35% Retailer Markup, Time-Invariant Tax UnitsOpen System E-cigarette Taxes by State/County from 2010 to 2023, 35% Retailer Markup, Time-Invariant Tax Units 1st Edition:Publication: Cotti, Chad, Erik Nesson, Michael F. Pesko, Serena Phillips, and Nathan Tefft. "Standardising the measurement of e-cigarette taxes in the USA, 2010–2020." Tobacco control 32, no. e2 (2023): e251-e254.PubMed LInk: https://pubmed.ncbi.nlm.nih.gov/34911814/Download: E-cig Tax Version 1, 2010-2020.xlsxDescription: The downloadable Excel file includes 3 tabs:E-cigarette Taxes by State/County from 2010 to 2020, 35% Retailer Markup, Time-Invariant Tax UnitsE-cigarette Taxes by State/County from 2010 to 2020, 20% Retailer Markup, Time-Invariant Tax UnitsE-cigarette Taxes by State/County from 2010 to 2020, 35% Retailer Markup, Time-Varying Tax UnitsIndoor Air LawsThis database reports US national- and state-level estimates of population coverage of comprehensive and partial indoor smoking restrictions from 1990 to 2021 for bars, restaurants, and workplaces, and comprehensive indoor vaping restrictions from 2006 to 2021 for the same locations. Estimates were calculated by using policy data from the American Nonsmokers' Rights Foundation. 1st Edition:Publication: Seidenberg, Andrew B., Karl Braganza, Maxwell Chomas, Megan C. Diaz, Abigail S. Friedman, Serena Phillips, and Michael Pesko. "Coverage of Indoor Smoking and Vaping Restrictions in the US, 1990-2021." American Journal of Preventive Medicine (2024).67, no. 4 (2024): 494-502.PubMed LInk: https://pubmed.ncbi.nlm.nih.gov/38876294/Download: Vaping and Smoking Indoor Air Laws Version 1, 2010-2021.xlsxResearch reported in this project was supported by the National Institute On Drug Abuse of the National Institutes of Health under Award Number R01DA045016. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The Population Assessment of Tobacco and Health (PATH) Study began originally surveying 45,971 adult and youth respondents. The PATH Study was launched in 2011 to inform Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of people who use or do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled Primary Sampling Unit (PSU)s and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort.Dataset 0001 (DS0001) contains the data from the Master Linkage file. This file contains 14 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were for each wave. At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This second replenishment sample was combined for estimation and analysis purposes with Wave 7 adult and youth respondents from the Wave 4 Cohort who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7. This combined set of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort. Please refer to the Public-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts.Dataset 1001 (DS1001) contains the data from the Wave 1 Adult Questionnaire. This data file contains 1,732 variables and 32,320 cases. Each of the cases represents a single, completed interview. Dataset 1002 (DS1002) contains the data from the Youth and Parent Questionnaire. This file contains 1,228 variables and 13,651 cases.Dataset 2001 (DS2001) contains the data from the Wave 2 Adult Questionnaire. This data file contains 2,197 variables and 28,362 cases. Of these cases, 26,447 also completed a Wave 1 Adult Questionnaire. The other 1,915 cases are "aged-up adults" having previously completed a Wave 1 Youth Questionnaire. Dataset 2002 (DS2002) contains the data from the Wave 2 Youth and Parent Questionnaire. This data file contains 1,389 variables and 12,172 cases. Of these cases, 10,081 also completed a Wave 1 Youth Questionnaire. The other 2,091 cases are "aged-up youth" having previously been sampled as "shadow youth." Dataset 3001 (DS3001) contains the data from the Wave 3 Adult Questionnaire. This data file contains 2,139 variables and 28,148 cases. Of these cases, 26,241 are continuing adults having completed a prior Adult Questionnaire. The other 1,907 cases are "aged-up adults" having previously completed a Youth Questionnaire. Dataset 3002 (DS3002) contains the data from t

In this follow-up to the National Health Interview Survey (NHIS), teenagers were interviewed to obtain information on tobacco use, including measures of prevalence, knowledge and attitudes, and predictors of taking up smoking. Respondents were asked if they smoked or used chewing tobacco or snuff, or had in the past. If so, they were questioned as to when they started, how much they smoked, chewed, or snuffed during the last month, where they bought cigarettes, which brand of cigarettes, chewing tobacco, or snuff they usually bought, how many times they tried to stop these habits, and what was the longest time they stopped smoking cigarettes since they started smoking regularly. Nonsmokers were asked if they thought they might start smoking, if they had experimented with cigarette smoking, if they had ever been offered a cigarette, and how difficult it would be to obtain tobacco if they wanted to. The survey asked respondents if any of their household members, teachers, or friends smoked, if they had heard anything about the health risks of tobacco use on television, radio, or in newspapers or magazines, and if they believed that chewing tobacco or using snuff causes cancer. Attitudes toward tobacco use were also probed with questions such as whether respondents disliked being around people who smoked, whether they believed it was safe to smoke for only a year or two, if they preferred to date people who didn't smoke, if they thought they could stop smoking any time they wanted to, whether they thought their friends approved or disapproved of their smoking, chewing, or snuffing, and if they thought their parents would mind if they smoked when they were older. Respondents were also asked if they believed there was any harm in having an occasional cigarette, and if they believed smoking helps people to relax, to keep down their weight, and to reduce boredom and stress. In addition to questions about tobacco use, the survey queried respondents about their attitudes regarding seat belts, fitness, alcohol, marijuana, drugs in general, school, and diet. They were also asked whether, during the last year, they had been in an accident or physical fight, had been in a car with a drunk driver, or had ridden on a motorcycle, and how often they had trouble going to sleep, felt unhappy or depressed, felt hopeless about the future, felt nervous or tense, or worried too much. Demographic and socioeconomic information provided in the data file includes respondents' race, education, and geographic region, reference persons' race, education, occupation, and marital status, presence of parent(s) or other adult relative in household, family income, and education of the adult.

US: Smoking Prevalence: Females: % of Adults data was reported at 19.100 % in 2016. This records a decrease from the previous number of 19.600 % for 2015. US: Smoking Prevalence: Females: % of Adults data is updated yearly, averaging 21.100 % from Dec 2000 (Median) to 2016, with 9 observations. The data reached an all-time high of 28.400 % in 2000 and a record low of 19.100 % in 2016. US: Smoking Prevalence: Females: % of Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of smoking, female is the percentage of women ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis. It excludes smokeless tobacco use. The rates are age-standardized.; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;